跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 102 条关于
“Qilu”
全部
102
临床试验
5
药物
62
机构
6
资讯
29
7个月前
Qilu Pharmaceutical Partners with Insilico Medicine in $120 Million AI-Driven Metabolic Disease Drug Development Deal
去年
Qilu Pharmaceutical's QLS32015 Shows Promise in Relapsed/Refractory Multiple Myeloma
去年
Minghui and Qilu Pharmaceuticals Partner on B7-H3 ADC Development in $210 Million Deal for Greater China
去年
Alteogen's Aflibercept Biosimilar Eyluxvi Receives Positive Opinion from European Medicines Agency
上个月
China's NMPA Accepts New Drug Application for Laekna's AKT Inhibitor Afuresertib in HR+/HER2- Breast Cancer
9个月前
RNA Drug Pioneer RiboBio Passes Hong Kong IPO Hearing with $2B+ Partnership Portfolio
去年
Arbutus Reacquires Global Rights to Hepatitis B RNAi Therapy After Achieving Functional Cure in Eight Patients
去年
Global Review of Pyelonephritis Clinical Trials Reveals Key Trends and Top Companies
2年前
Iruplinalkib Shows Sustained Benefit in Crizotinib-Resistant NSCLC
上个月
EMA recommends approval for biosimilar pegfilgrastim Cavoley
第 1 页,共 3 页
上一页
下一页